Acinetobacter baumannii
A Targeted Treatment for Carbapenem-Resistant Acinetobacter baumannii
The approval of sulbactam-durlobactam for the treatment of carbapenem-resistant Acinetobacter baumannii infections ...
APRIL 1, 2025
Sulbactam-Durlobactam Promising for Serious Acinetobacter Infections
Although its prevalence in the United States has declined from a peak in the late 1990s, treatment of Acinetobacter ...
JULY 13, 2023
Xerava Shows Promise For Treating CRAB
Combination therapy with eravacycline shows favorable clinical and microbiological outcomes among patients with ...
OCTOBER 24, 2022
Load more